FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.120
-0.100 (-8.20%)
Apr 28, 2025, 9:35 AM EDT - Market open

FibroBiologics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-11.16-16.49-5.12-1.58-1.17
Depreciation & Amortization
0.570.440.09--
Other Amortization
-0.080.39--
Stock-Based Compensation
2.221.770.27--
Other Operating Activities
-4.097.31---
Change in Accounts Payable
1.250.670.530.23-
Change in Other Net Operating Assets
-0.69-0.18-0.22-0.06-
Operating Cash Flow
-11.9-6.4-4.07-1.41-1.17
Capital Expenditures
-0.18-0.5---
Investing Cash Flow
-0.18-0.5---
Short-Term Debt Issued
9.97-4.32.28-
Total Debt Issued
9.97-4.32.28-
Short-Term Debt Repaid
-0.57--0.23-0.75-
Total Debt Repaid
-0.57--0.23-0.75-
Net Debt Issued (Repaid)
9.4-4.081.53-
Issuance of Common Stock
7.51--0.291.17
Other Financing Activities
--2.35-0.3--
Financing Cash Flow
16.9113.795.931.821.17
Net Cash Flow
4.826.91.860.41-
Free Cash Flow
-12.09-6.9-4.07-1.41-1.17
Free Cash Flow Per Share
-0.37-0.24-0.14-0.16-0.13
Cash Interest Paid
0.020---
Levered Free Cash Flow
-11.853.97-1.69--
Unlevered Free Cash Flow
-11.833.98-1.67--
Change in Net Working Capital
5.86-7.83-0.77--
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q